CClinicalTrials.gg
Status unknownNCT03708523Updated Oct 17, 2018

Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy

An observational study in Hypopituitarism, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2018-10-17.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Oct 2018), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-crossover
Time perspective
Retrospective
Enrollment
400
Ages
20 Years and older
Sex
All
01

Study summary

This study tried to highlight the predictive value of the morning postoperative cortisol levels, which can act as the prognosis value of the postoperative pituitary function, providing future medication advices for improving patients' safety of drugs.

Read the detailed description

Transsphenoidal adenomectomy usually accompanied by the failure or recovery of the pituitary gland, which usually causing further hypopituitarism and hormone recovery. In order to prevent the potential applications of adrenal cortical malfunction after the surgery, many medical centers will use glucocorticoid supplements during the perioperative period care. However, this treatment might expose the normal hypothalamic-pituitary-adrenal (HPA) axis function patients into potential threats after the treatment of glucocorticoid supplements, such as bone loss, hypertension, emotional distress, and weight gain. To avoid unnecessary supply of glucocorticoids, the key question is to monitor the pituitary function. Thus, in this study we try to predict the morning postoperative cortisol levels, for further prediction of the postoperative pituitary function. To do so, we will review the retrospective charts of transsphenoidal adenomectomied patients from January, 2013 to April, 2018 in the NTUH Taipei. Use statistical methods analyzing all sorts of medical reports, including perioperative hormone thresholds.This study tried to highlight the predictive value of the morning postoperative cortisol levels, which can act as the prognosis value of the postoperative pituitary function, providing future medication advices for improving patients' safety of drugs.

02

Conditions studied

  • Hypopituitarism

Keywords

  • Hypopituitarism,Pituitary function
03

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who had been treated with TSA were enrolled.

Inclusion criteria

Patients who had been treated with TSA were enrolled.

Exclusion criteria

Exclusion:

  1. Hypopituitarism preoperatively.
  2. Acromegaly
  3. Multiple operations
  4. Incomplete hormone data or loss of follow-up
04

Study design

Observational model
Case-crossover
Time perspective
Retrospective
Enrollment
400 participants (estimated)
05

What researchers measure

Primary outcomes

  1. Next Day Early Morning Growth Hormone as Predictor of Pituitary Function After Transsphenoidal Adenomectomy

    To predict the morning postoperative cortisol levels, for further prediction of the postoperative pituitary function.

    Time frame: 2 days

06

Study locations

1 site
  • National Taiwan University Hospital
    Taipei city, 100, Taiwan
07

Registry details

Key details

Study ID
NCT03708523
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Oct 17, 2018
Start date
Nov 1, 2018 (estimated)
Primary completion
Sep 2019 (estimated)
Completion
Sep 2019 (estimated)
Last update
Oct 17, 2018

Study contacts

Fon-Yih Tsuang
Contact
tsuangfy@gmail.com
0972651142
Fon-Yih Tsuang, MD
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion